已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

N6 -Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression

癌症研究 索拉非尼 六氯环己烷 生物 肝细胞癌 癌症干细胞 干细胞 下调和上调 细胞生物学 基因 生物化学
作者
Xinyue Zhang,Tianhong Su,Yifan Wu,Yuhong Cai,Lina Wang,Cong Liang,Lei Zhou,Shiyan Wang,Xiaoxing Li,Sui Peng,Ming Kuang,Jun Qing Yu,Lixia Xu
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6): 827-840 被引量:104
标识
DOI:10.1158/0008-5472.can-23-1916
摘要

N6-methyladenosine (m6A) RNA modification is the most common and conserved epigenetic modification in mRNA and has been shown to play important roles in cancer biology. As the m6A reader YTHDF1 has been reported to promote progression of hepatocellular carcinoma (HCC), it represents a potential therapeutic target. In this study, we evaluated the clinical significance of YTHDF1 using human HCC samples and found that YTHDF1 was significantly upregulated in HCCs with high stemness scores and was positively associated with recurrence and poor prognosis. Analysis of HCC spheroids revealed that YTHDF1 was highly expressed in liver cancer stem cells (CSC). Stem cell-specific conditional Ythdf1 knockin (CKI) mice treated with diethylnitrosamine showed elevated tumor burden as compared with wild-type mice. YTHDF1 promoted CSCs renewal and resistance to the multiple tyrosine kinase inhibitors lenvatinib and sorafenib in patient-derived organoids and HCC cell lines, which could be abolished by catalytically inactive mutant YTHDF1. Multiomic analysis, including RNA immunoprecipitation sequencing, m6A methylated RNA immunoprecipitation sequencing, ribosome profiling, and RNA sequencing identified NOTCH1 as a direct downstream of YTHDF1. YTHDF1 bound to m6A modified NOTCH1 mRNA to enhance its stability and translation, which led to increased NOTCH1 target genes expression. NOTCH1 overexpression rescued HCC stemness in YTHDF1-deficient cells in vitro and in vivo. Lipid nanoparticles targeting YTHDF1 significantly enhanced the efficacy of lenvatinib and sorafenib in HCC in vivo. Taken together, YTHDF1 drives HCC stemness and drug resistance through an YTHDF1-m6A-NOTCH1 epitranscriptomic axis, and YTHDF1 is a potential therapeutic target for treating HCC. SIGNIFICANCE: Inhibition of YTHDF1 expression suppresses stemness of hepatocellular carcinoma cells and enhances sensitivity to targeted therapies, indicating that targeting YTHDF1 may be a promising therapeutic strategy for liver cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kk发布了新的文献求助10
1秒前
勤劳的瑀发布了新的文献求助10
2秒前
CodeCraft的应助被tangtang采纳,获得10
5秒前
5秒前
童diedie完成签到,获得积分10
6秒前
7秒前
8秒前
8秒前
醉猫完成签到,获得积分10
9秒前
野生欧包完成签到 ,获得积分10
9秒前
Maestro_S的应助被Liao采纳,获得10
9秒前
10秒前
研友_Zrl9aL完成签到,获得积分10
11秒前
ztt完成签到,获得积分10
12秒前
尼古拉斯铁柱完成签到 ,获得积分10
12秒前
14秒前
15秒前
17秒前
炫烟完成签到,获得积分10
20秒前
tangtang发布了新的文献求助10
21秒前
yyds的应助被TICJ采纳,获得10
22秒前
PhysicsXX完成签到,获得积分10
22秒前
Jasper的应助被坚定的觅风采纳,获得10
23秒前
outlast完成签到,获得积分10
23秒前
潇澜发布了新的文献求助10
23秒前
Elsevier大王的应助被Xenomorph采纳,获得30
25秒前
28秒前
研友_Zrl9aL发布了新的文献求助50
28秒前
30秒前
炸家7蛋完成签到,获得积分10
33秒前
拼搏幻柏完成签到,获得积分10
33秒前
潇澜完成签到,获得积分10
36秒前
sky发布了新的文献求助10
36秒前
hehe发布了新的文献求助10
38秒前
42秒前
kai完成签到 ,获得积分10
43秒前
barn完成签到 ,获得积分10
43秒前
caspar完成签到,获得积分10
53秒前
wefun完成签到,获得积分10
54秒前
CipherSage的应助被u132237采纳,获得10
55秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194894
求助须知:如何正确求助?哪些是违规求助? 9580685
关于积分的说明 21872290
捐赠科研通 7794613
什么是DOI,文献DOI怎么找? 3437801
关于科研通互助平台的介绍 2561143
邀请新用户注册赠送积分活动 2484511